| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | RIPK3 TRIO PDK4 STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK PIK3CA FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 1.53e-09 | 600 | 128 | 20 | GO:0004672 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.38e-09 | 145 | 128 | 11 | GO:0004713 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | RIPK3 TRIO PDK4 STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK PIK3CA FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 2.54e-08 | 709 | 128 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | RIPK3 TRIO PDK4 STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK PIK3CA FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 8.63e-08 | 764 | 128 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RIPK3 TRIO PDK4 STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK PIK3CA FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 2.17e-06 | 938 | 128 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.11e-05 | 46 | 128 | 5 | GO:0004715 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.07e-05 | 65 | 128 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.64e-04 | 17 | 128 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.18e-04 | 85 | 128 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 5.61e-04 | 363 | 128 | 9 | GO:0106310 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | PDK4 ESR2 ROR1 SRC LMTK2 RET LCK YES1 SVEP1 RYK STAT5A STAT5B CUL5 GHSR MYOF PIK3CA FER HRG RABGEF1 BAIAP2 KIT EPHA10 | 1.36e-09 | 747 | 129 | 22 | GO:0007169 |
| GeneOntologyBiologicalProcess | response to stem cell factor | 9.52e-07 | 4 | 129 | 3 | GO:0036215 | |
| GeneOntologyBiologicalProcess | cellular response to stem cell factor stimulus | 9.52e-07 | 4 | 129 | 3 | GO:0036216 | |
| GeneOntologyBiologicalProcess | Kit signaling pathway | 9.52e-07 | 4 | 129 | 3 | GO:0038109 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TRIO PDK4 ESR2 ROR1 SRC LMTK2 RET LCK YES1 SVEP1 RYK STAT5A STAT5B CUL5 GHSR MYOF PIK3CA FER HRG RABGEF1 BAIAP2 KIT EPHA10 | 1.15e-06 | 1186 | 129 | 23 | GO:0007167 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | RIPK3 ROR1 SRC CAMK1 RET RYK PIK3CA FZD5 NEURL1 MAP3K10 KIF14 KIT | 9.24e-06 | 405 | 129 | 12 | GO:0033674 |
| GeneOntologyBiologicalProcess | response to hormone | HTR1B PDK4 ESR2 SRC CPN1 CCKAR STAT5A STAT5B PHEX GHSR OTC GTF2H1 ARSB PLPP1 PIK3CA FER BAIAP2 PADI2 NPAS4 | 2.59e-05 | 1042 | 129 | 19 | GO:0009725 |
| GeneOntologyBiologicalProcess | T cell differentiation | THEMIS RIPK3 CHD7 LCK STAT5A STAT5B KLHL25 FZD5 BTN2A3P SEMA4A KIT | 2.88e-05 | 382 | 129 | 11 | GO:0030217 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | THEMIS RIPK3 CHD7 LCK CR2 STAT5A STAT5B KLHL25 FZD5 BTN2A3P SEMA4A KIT HECTD1 | 3.28e-05 | 537 | 129 | 13 | GO:0030098 |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | 3.73e-05 | 393 | 129 | 11 | GO:0002768 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 4.31e-05 | 62 | 129 | 5 | GO:0038093 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | PDK4 ESR2 SRC CCKAR STAT5A STAT5B PHEX GHSR GTF2H1 PLPP1 PIK3CA FER BAIAP2 PADI2 NPAS4 | 5.02e-05 | 727 | 129 | 15 | GO:0032870 |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 5.05e-05 | 12 | 129 | 3 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | RIPK3 ROR1 SRC CAMK1 RET RYK PIK3CA FZD5 NEURL1 MAP3K10 KIF14 KIT | 5.98e-05 | 490 | 129 | 12 | GO:0051347 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ROR1 SRC OBSL1 CAMK1 RET ARSB PIK3CA RAB3IP NEURL1 AFDN BAIAP2 KIT | 6.46e-05 | 494 | 129 | 12 | GO:0031346 |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 6.53e-05 | 13 | 129 | 3 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 6.53e-05 | 13 | 129 | 3 | GO:0048541 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | KCTD19 SMCHD1 ESR2 SRC CHD7 DNAAF11 CFAP43 RNF17 ZNF595 STAT5A STAT5B GHSR PIK3CA FZD5 NEURL1 CCDC87 FER PLG KIT HECTD1 | 8.23e-05 | 1235 | 129 | 20 | GO:0003006 |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 8.27e-05 | 14 | 129 | 3 | GO:0046645 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 9.54e-05 | 228 | 129 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | cell activation | THEMIS RIPK3 SRC CHD7 LCK TEC CR2 YES1 SVEP1 STAT5A STAT5B KLHL25 PIK3CA FZD5 BTN2A3P FER HRG RABGEF1 SEMA4A KIT HECTD1 | 1.01e-04 | 1356 | 129 | 21 | GO:0001775 |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 1.03e-04 | 15 | 129 | 3 | GO:0045586 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 1.06e-04 | 442 | 129 | 11 | GO:0050878 | |
| GeneOntologyBiologicalProcess | positive regulation of small intestine smooth muscle contraction | 1.16e-04 | 3 | 129 | 2 | GO:1904349 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 1.16e-04 | 3 | 129 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 1.22e-04 | 449 | 129 | 11 | GO:0050900 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 1.24e-04 | 41 | 129 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | T cell activation | THEMIS RIPK3 SRC CHD7 LCK YES1 STAT5A STAT5B KLHL25 PIK3CA FZD5 BTN2A3P SEMA4A KIT | 1.28e-04 | 701 | 129 | 14 | GO:0042110 |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 1.52e-04 | 17 | 129 | 3 | GO:0046643 | |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 1.52e-04 | 17 | 129 | 3 | GO:0036159 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | THEMIS RIPK3 CHD7 LCK CR2 STAT5A STAT5B KLHL25 FZD5 BTN2A3P SEMA4A KIT HECTD1 | 1.91e-04 | 640 | 129 | 13 | GO:1903131 |
| GeneOntologyBiologicalProcess | positive regulation of multicellular organism growth | 2.11e-04 | 47 | 129 | 4 | GO:0040018 | |
| GeneOntologyBiologicalProcess | mast cell migration | 2.15e-04 | 19 | 129 | 3 | GO:0097531 | |
| GeneOntologyBiologicalProcess | negative regulation of anoikis | 2.15e-04 | 19 | 129 | 3 | GO:2000811 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 2.15e-04 | 19 | 129 | 3 | GO:0051917 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 2.20e-04 | 327 | 129 | 9 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 2.30e-04 | 329 | 129 | 9 | GO:0018212 | |
| GeneOntologyBiologicalProcess | blood coagulation | 2.35e-04 | 260 | 129 | 8 | GO:0007596 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 2.52e-04 | 198 | 129 | 7 | GO:0007259 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell differentiation | 2.52e-04 | 20 | 129 | 3 | GO:0042492 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ROR1 SRC OBSL1 CAMK1 RET RYK ARSB PIK3CA RAB3IP NEURL1 FER HRG AFDN BAIAP2 KIT | 2.66e-04 | 846 | 129 | 15 | GO:0120035 |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 2.69e-04 | 50 | 129 | 4 | GO:0044331 | |
| GeneOntologyBiologicalProcess | coagulation | 2.74e-04 | 266 | 129 | 8 | GO:0050817 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | RIPK3 SRC LCK TEC YES1 SVEP1 STAT5A STAT5B KLHL25 PIK3CA BTN2A3P FER HRG RABGEF1 | 2.78e-04 | 756 | 129 | 14 | GO:0050865 |
| GeneOntologyBiologicalProcess | hemostasis | 2.88e-04 | 268 | 129 | 8 | GO:0007599 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 2.91e-04 | 51 | 129 | 4 | GO:0031295 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 2.93e-04 | 21 | 129 | 3 | GO:2000047 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 2.96e-04 | 93 | 129 | 5 | GO:0040014 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ROR1 SRC OBSL1 CAMK1 RET RYK ARSB PIK3CA RAB3IP NEURL1 FER HRG AFDN BAIAP2 KIT | 3.28e-04 | 863 | 129 | 15 | GO:0031344 |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 3.37e-04 | 53 | 129 | 4 | GO:0031294 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 3.62e-04 | 350 | 129 | 9 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of activated T cell proliferation | 3.63e-04 | 54 | 129 | 4 | GO:0046006 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RIPK3 ROR1 SRC CAMK1 RET RYK GTF2H1 PIK3CA FZD5 NEURL1 MAP3K10 KIF14 KIT | 3.72e-04 | 686 | 129 | 13 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RIPK3 ROR1 SRC CAMK1 RET LCK YES1 RYK PIK3CA FZD5 NEURL1 MAP3K10 KIF14 KIT | 3.80e-04 | 780 | 129 | 14 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of small intestine smooth muscle contraction | 3.83e-04 | 5 | 129 | 2 | GO:1904347 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 3.83e-04 | 5 | 129 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | digestive tract development | 3.92e-04 | 152 | 129 | 6 | GO:0048565 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | THEMIS RIPK3 SRC CHD7 LCK CR2 YES1 STAT5A STAT5B KLHL25 PIK3CA FZD5 BTN2A3P SEMA4A KIT HECTD1 | 3.94e-04 | 976 | 129 | 16 | GO:0046649 |
| GeneOntologyBiologicalProcess | lamellipodium organization | 3.96e-04 | 99 | 129 | 5 | GO:0097581 | |
| GeneOntologyBiologicalProcess | leukocyte activation | THEMIS RIPK3 SRC CHD7 LCK CR2 YES1 STAT5A STAT5B KLHL25 PIK3CA FZD5 BTN2A3P FER RABGEF1 SEMA4A KIT HECTD1 | 4.24e-04 | 1186 | 129 | 18 | GO:0045321 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 4.26e-04 | 216 | 129 | 7 | GO:0097696 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | THEMIS RIPK3 SRC CHD7 LCK CR2 STAT5A STAT5B KLHL25 FZD5 BTN2A3P SEMA4A KIT HECTD1 | 4.27e-04 | 789 | 129 | 14 | GO:0002521 |
| GeneOntologyBiologicalProcess | regulation of immune response | THEMIS RIPK3 SRC LCK TEC CR2 YES1 SVEP1 STAT5A STAT5B PIK3CA FZD5 BTN2A3P FER HRG RABGEF1 KIT | 4.32e-04 | 1085 | 129 | 17 | GO:0050776 |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 4.35e-04 | 359 | 129 | 9 | GO:0002429 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium organization | 4.46e-04 | 57 | 129 | 4 | GO:1902743 | |
| GeneOntologyBiologicalProcess | female sex differentiation | 4.65e-04 | 157 | 129 | 6 | GO:0046660 | |
| GeneOntologyBiologicalProcess | platelet activation | 4.81e-04 | 158 | 129 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 4.87e-04 | 290 | 129 | 8 | GO:0050870 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RIPK3 ROR1 SRC CAMK1 RET RYK GTF2H1 PIK3CA FZD5 HPF1 NEURL1 MAP3K10 KIF14 KIT | 5.53e-04 | 810 | 129 | 14 | GO:0051338 |
| GeneOntologyBiologicalProcess | regulation of anoikis | 5.59e-04 | 26 | 129 | 3 | GO:2000209 | |
| GeneOntologyBiologicalProcess | small intestine smooth muscle contraction | 5.73e-04 | 6 | 129 | 2 | GO:1990770 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell proliferation | 5.73e-04 | 6 | 129 | 2 | GO:0070668 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | RIPK3 NEXMIF SRC RET RYK STAT5A STAT5B GHSR ARSB PGAM4 FER KIF14 HRG AFDN RABGEF1 SEMA4A PLG KIT PADI2 | 5.94e-04 | 1327 | 129 | 19 | GO:0040012 |
| GeneOntologyBiologicalProcess | axoneme assembly | 6.15e-04 | 109 | 129 | 5 | GO:0035082 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RIPK3 ROR1 SRC CAMK1 RET LCK YES1 RYK GTF2H1 PIK3CA FZD5 NEURL1 FER MAP3K10 KIF14 HRG RABGEF1 KIT | 6.26e-04 | 1226 | 129 | 18 | GO:0042325 |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell apoptotic process | 6.26e-04 | 27 | 129 | 3 | GO:0033033 | |
| GeneOntologyBiologicalProcess | digestive system development | 6.45e-04 | 167 | 129 | 6 | GO:0055123 | |
| GeneOntologyBiologicalProcess | response to lipid | BRINP3 HTR1B PDK4 ESR2 SRC CPN1 RET CR2 YES1 STAT5B PHEX GHSR PLPP1 PIK3CA FER PADI2 NPAS4 | 6.57e-04 | 1126 | 129 | 17 | GO:0033993 |
| GeneOntologyBiologicalProcess | response to steroid hormone | 6.66e-04 | 381 | 129 | 9 | GO:0048545 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | NEXMIF SRC RET LCK YES1 STAT5A STAT5B KLHL25 LMO7 PIK3CA BTN2A3P KIF14 HRG AFDN PLG | 6.91e-04 | 927 | 129 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | activated T cell proliferation | 7.36e-04 | 65 | 129 | 4 | GO:0050798 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 7.37e-04 | 309 | 129 | 8 | GO:0002703 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 7.72e-04 | 389 | 129 | 9 | GO:0022409 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 7.75e-04 | 29 | 129 | 3 | GO:0042730 | |
| GeneOntologyBiologicalProcess | positive regulation of gastro-intestinal system smooth muscle contraction | 7.99e-04 | 7 | 129 | 2 | GO:1904306 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | THEMIS SRC LCK TEC CR2 YES1 SVEP1 STAT5A STAT5B PIK3CA FZD5 BTN2A3P HRG RABGEF1 | 8.36e-04 | 845 | 129 | 14 | GO:0050778 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 8.70e-04 | 317 | 129 | 8 | GO:1903039 | |
| GeneOntologyBiologicalProcess | response to platelet-derived growth factor | 9.45e-04 | 31 | 129 | 3 | GO:0036119 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 9.73e-04 | 70 | 129 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 1.03e-03 | 251 | 129 | 7 | GO:0060491 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | SRC RET LCK YES1 STAT5A STAT5B KLHL25 PIK3CA BTN2A3P HRG AFDN | 1.04e-03 | 579 | 129 | 11 | GO:0045785 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | NEXMIF SRC LCK YES1 STAT5A STAT5B KLHL25 PIK3CA BTN2A3P AFDN PLG | 1.06e-03 | 580 | 129 | 11 | GO:0022407 |
| GeneOntologyBiologicalProcess | protein localization to motile cilium | 1.06e-03 | 8 | 129 | 2 | GO:0120229 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 1.06e-03 | 8 | 129 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | mast cell differentiation | 1.06e-03 | 8 | 129 | 2 | GO:0060374 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 1.10e-03 | 185 | 129 | 6 | GO:0031960 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NEXMIF SRC RET LCK YES1 SVEP1 STAT5A STAT5B KLHL25 PIK3CA BTN2A3P FER AFDN BAIAP2 PLG KIT | 1.13e-03 | 1077 | 129 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 1.14e-03 | 33 | 129 | 3 | GO:0046629 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RIPK3 ROR1 SRC CAMK1 RET LCK YES1 RYK PIK3CA FZD5 NEURL1 MAP3K10 KIF14 KIT | 1.22e-03 | 879 | 129 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RIPK3 ROR1 SRC CAMK1 RET LCK YES1 RYK PIK3CA FZD5 NEURL1 MAP3K10 KIF14 KIT | 1.22e-03 | 879 | 129 | 14 | GO:0010562 |
| GeneOntologyCellularComponent | Golgi to plasma membrane transport vesicle | 3.90e-05 | 2 | 131 | 2 | GO:0070319 | |
| GeneOntologyCellularComponent | cell-cell junction | THEMIS OBSL1 LCK TEC GJA9 LMO7 PIK3CA FZD5 FER AFDN BAIAP2 KIT | 3.48e-04 | 591 | 131 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.20e-04 | 56 | 131 | 4 | GO:0099091 | |
| HumanPheno | Angioedema | 4.66e-06 | 13 | 48 | 4 | HP:0100665 | |
| Domain | Pkinase_Tyr | ROR1 SRC LMTK2 RET LCK TEC YES1 RYK FER MAP3K10 MAP3K21 KIT EPHA10 | 4.76e-12 | 129 | 128 | 13 | PF07714 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | ROR1 SRC LMTK2 RET LCK TEC YES1 RYK FER MAP3K10 MAP3K21 KIT EPHA10 | 1.13e-11 | 138 | 128 | 13 | IPR001245 |
| Domain | Tyr_kinase_cat_dom | 2.07e-11 | 88 | 128 | 11 | IPR020635 | |
| Domain | TyrKc | 2.07e-11 | 88 | 128 | 11 | SM00219 | |
| Domain | PROTEIN_KINASE_TYR | 6.12e-11 | 97 | 128 | 11 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.12e-11 | 97 | 128 | 11 | IPR008266 | |
| Domain | PROTEIN_KINASE_ATP | RIPK3 TRIO STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 2.42e-09 | 459 | 128 | 18 | PS00107 |
| Domain | Kinase-like_dom | RIPK3 TRIO STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK PIK3CA FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 5.27e-09 | 542 | 128 | 19 | IPR011009 |
| Domain | Prot_kinase_dom | RIPK3 TRIO STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 6.52e-09 | 489 | 128 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | RIPK3 TRIO STK17A ROR1 SRC LMTK2 CAMK1 RET LCK TEC YES1 RYK FER MAP3K10 MAP3K21 KIT EPHA10 DYRK2 | 7.40e-09 | 493 | 128 | 18 | PS50011 |
| Domain | Protein_kinase_ATP_BS | RIPK3 STK17A SRC LMTK2 CAMK1 RET LCK TEC YES1 FER MAP3K10 MAP3K21 KIT DYRK2 | 3.39e-07 | 379 | 128 | 14 | IPR017441 |
| Domain | SH2 | 6.07e-06 | 101 | 128 | 7 | PF00017 | |
| Domain | SH2 | 1.07e-05 | 110 | 128 | 7 | SM00252 | |
| Domain | SH2 | 1.13e-05 | 111 | 128 | 7 | PS50001 | |
| Domain | SH2 | 1.20e-05 | 112 | 128 | 7 | IPR000980 | |
| Domain | - | 1.20e-05 | 112 | 128 | 7 | 3.30.505.10 | |
| Domain | Sec2_N | 4.66e-05 | 2 | 128 | 2 | IPR009449 | |
| Domain | Sec2p | 4.66e-05 | 2 | 128 | 2 | PF06428 | |
| Domain | SH3 | 1.22e-04 | 216 | 128 | 8 | SM00326 | |
| Domain | SH3 | 1.22e-04 | 216 | 128 | 8 | PS50002 | |
| Domain | SH3_1 | 1.37e-04 | 164 | 128 | 7 | PF00018 | |
| Domain | SH3_domain | 1.39e-04 | 220 | 128 | 8 | IPR001452 | |
| Domain | MLK1/MLK2/MLK4 | 2.77e-04 | 4 | 128 | 2 | IPR016231 | |
| Domain | MAP3K10 | 2.77e-04 | 4 | 128 | 2 | IPR015785 | |
| Domain | Chromo_domain | 5.73e-04 | 24 | 128 | 3 | IPR023780 | |
| Domain | Chromo | 7.28e-04 | 26 | 128 | 3 | PF00385 | |
| Domain | CHROMO_1 | 9.09e-04 | 28 | 128 | 3 | PS00598 | |
| Domain | CHROMO_2 | 9.09e-04 | 28 | 128 | 3 | PS50013 | |
| Domain | STAT_TF_DNA-bd_sub | 9.57e-04 | 7 | 128 | 2 | IPR012345 | |
| Domain | STAT | 9.57e-04 | 7 | 128 | 2 | IPR001217 | |
| Domain | Pan_app | 9.57e-04 | 7 | 128 | 2 | IPR003609 | |
| Domain | STAT_int | 9.57e-04 | 7 | 128 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 9.57e-04 | 7 | 128 | 2 | IPR013801 | |
| Domain | STAT_bind | 9.57e-04 | 7 | 128 | 2 | PF02864 | |
| Domain | STAT_int | 9.57e-04 | 7 | 128 | 2 | PF02865 | |
| Domain | - | 9.57e-04 | 7 | 128 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 9.57e-04 | 7 | 128 | 2 | PF01017 | |
| Domain | - | 9.57e-04 | 7 | 128 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 9.57e-04 | 7 | 128 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 9.57e-04 | 7 | 128 | 2 | IPR015988 | |
| Domain | PAN | 9.57e-04 | 7 | 128 | 2 | PS50948 | |
| Domain | - | 9.57e-04 | 7 | 128 | 2 | 2.60.40.630 | |
| Domain | PAN_1 | 9.57e-04 | 7 | 128 | 2 | PF00024 | |
| Domain | STAT_TF_alpha | 1.27e-03 | 8 | 128 | 2 | IPR013800 | |
| Domain | Chromodomain-like | 1.35e-03 | 32 | 128 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.48e-03 | 33 | 128 | 3 | IPR000953 | |
| Domain | CHROMO | 1.48e-03 | 33 | 128 | 3 | SM00298 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.02e-03 | 14 | 128 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.02e-03 | 14 | 128 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.02e-03 | 14 | 128 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.02e-03 | 14 | 128 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.02e-03 | 14 | 128 | 2 | IPR011704 | |
| Domain | MT | 4.02e-03 | 14 | 128 | 2 | PF12777 | |
| Domain | AAA_8 | 4.02e-03 | 14 | 128 | 2 | PF12780 | |
| Domain | AAA_5 | 4.02e-03 | 14 | 128 | 2 | PF07728 | |
| Domain | DHC_fam | 4.62e-03 | 15 | 128 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.62e-03 | 15 | 128 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.62e-03 | 15 | 128 | 2 | IPR004273 | |
| Domain | RING | 5.09e-03 | 305 | 128 | 7 | SM00184 | |
| Domain | SMAD_FHA_domain | 5.44e-03 | 52 | 128 | 3 | IPR008984 | |
| Domain | IGc2 | 5.65e-03 | 235 | 128 | 6 | SM00408 | |
| Domain | Ig_sub2 | 5.65e-03 | 235 | 128 | 6 | IPR003598 | |
| Domain | Kringle_CS | 5.93e-03 | 17 | 128 | 2 | IPR018056 | |
| Domain | KRINGLE_1 | 5.93e-03 | 17 | 128 | 2 | PS00021 | |
| Domain | KR | 5.93e-03 | 17 | 128 | 2 | SM00130 | |
| Domain | Kringle | 5.93e-03 | 17 | 128 | 2 | IPR000001 | |
| Domain | KRINGLE_2 | 5.93e-03 | 17 | 128 | 2 | PS50070 | |
| Domain | Kringle | 5.93e-03 | 17 | 128 | 2 | PF00051 | |
| Domain | Chromodomain_CS | 6.64e-03 | 18 | 128 | 2 | IPR023779 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.48e-11 | 43 | 106 | 9 | M508 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 7.96e-11 | 20 | 106 | 7 | M39002 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.52e-10 | 37 | 106 | 8 | MM14564 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 5.46e-08 | 47 | 106 | 7 | M39380 | |
| Pathway | PID_PTP1B_PATHWAY | 1.13e-07 | 52 | 106 | 7 | M50 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 2.05e-06 | 13 | 106 | 4 | MM14565 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 5.13e-06 | 16 | 106 | 4 | M537 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 5.13e-06 | 16 | 106 | 4 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 5.13e-06 | 16 | 106 | 4 | MM1420 | |
| Pathway | PID_PDGFRB_PATHWAY | 5.63e-06 | 129 | 106 | 8 | M186 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.51e-05 | 71 | 106 | 6 | MM15947 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.77e-05 | 73 | 106 | 6 | M638 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 2.89e-05 | 48 | 106 | 5 | M914 | |
| Pathway | PID_KIT_PATHWAY | 4.29e-05 | 52 | 106 | 5 | M231 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 4.64e-05 | 27 | 106 | 4 | MM14712 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 4.77e-05 | 10 | 106 | 3 | MM15618 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 6.21e-05 | 29 | 106 | 4 | M779 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.71e-05 | 57 | 106 | 5 | MM14713 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 7.12e-05 | 30 | 106 | 4 | M257 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 7.12e-05 | 30 | 106 | 4 | M234 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.30e-05 | 58 | 106 | 5 | M2049 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 7.93e-05 | 59 | 106 | 5 | M39350 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 8.65e-05 | 12 | 106 | 3 | MM14835 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 8.65e-05 | 12 | 106 | 3 | M27893 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 8.65e-05 | 12 | 106 | 3 | M11773 | |
| Pathway | PID_NETRIN_PATHWAY | 9.23e-05 | 32 | 106 | 4 | M108 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.04e-04 | 33 | 106 | 4 | M11725 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 1.05e-04 | 100 | 106 | 6 | MM15879 | |
| Pathway | PID_CXCR4_PATHWAY | 1.05e-04 | 100 | 106 | 6 | M124 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.18e-04 | 34 | 106 | 4 | MM14992 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.32e-04 | 35 | 106 | 4 | MM15144 | |
| Pathway | PID_IL5_PATHWAY | 1.42e-04 | 14 | 106 | 3 | M135 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.83e-04 | 38 | 106 | 4 | M29803 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 2.16e-04 | 16 | 106 | 3 | M41733 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 2.47e-04 | 41 | 106 | 4 | MM15162 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 2.47e-04 | 41 | 106 | 4 | M159 | |
| Pathway | PID_NFKAPPAB_ATYPICAL_PATHWAY | 2.60e-04 | 17 | 106 | 3 | M26 | |
| Pathway | WP_PROLACTIN_SIGNALING | 2.64e-04 | 76 | 106 | 5 | M39601 | |
| Pathway | PID_TCPTP_PATHWAY | 2.71e-04 | 42 | 106 | 4 | M91 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 3.11e-04 | 18 | 106 | 3 | M673 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 3.11e-04 | 18 | 106 | 3 | MM15023 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.25e-04 | 44 | 106 | 4 | M1012 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 3.67e-04 | 19 | 106 | 3 | M41732 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 3.99e-04 | 83 | 106 | 5 | M27163 | |
| Pathway | PID_PI3KCI_PATHWAY | 4.56e-04 | 48 | 106 | 4 | M141 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 4.93e-04 | 49 | 106 | 4 | M92 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 4.98e-04 | 21 | 106 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 4.98e-04 | 21 | 106 | 3 | MM14996 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 5.33e-04 | 50 | 106 | 4 | M553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 5.52e-04 | 5 | 106 | 2 | M49006 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 5.52e-04 | 5 | 106 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 5.52e-04 | 5 | 106 | 2 | M48986 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 5.74e-04 | 22 | 106 | 3 | M7747 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | SRC LCK TEC YES1 STAT5A STAT5B CUL5 PIK3CA FER BAIAP2 PLG KIT | 6.43e-04 | 532 | 106 | 12 | M27870 |
| Pathway | WP_NRF2ARE_REGULATION | 6.56e-04 | 23 | 106 | 3 | M39761 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 6.56e-04 | 23 | 106 | 3 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 6.56e-04 | 23 | 106 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 6.56e-04 | 23 | 106 | 3 | M7897 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 7.26e-04 | 464 | 106 | 11 | M27547 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 7.46e-04 | 24 | 106 | 3 | M11520 | |
| Pathway | PID_IL2_1PATHWAY | 7.67e-04 | 55 | 106 | 4 | M122 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 8.24e-04 | 6 | 106 | 2 | MM15621 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K | 8.24e-04 | 6 | 106 | 2 | M27929 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 8.24e-04 | 6 | 106 | 2 | MM15581 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 8.43e-04 | 25 | 106 | 3 | M41829 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 8.43e-04 | 25 | 106 | 3 | M27865 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 8.43e-04 | 25 | 106 | 3 | MM1519 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 8.78e-04 | 57 | 106 | 4 | M19888 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 9.47e-04 | 26 | 106 | 3 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 9.47e-04 | 26 | 106 | 3 | MM15896 | |
| Pathway | PID_IL3_PATHWAY | 9.47e-04 | 26 | 106 | 3 | M182 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.06e-03 | 27 | 106 | 3 | M9043 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 1.06e-03 | 27 | 106 | 3 | M33 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 1.15e-03 | 7 | 106 | 2 | M27953 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 1.15e-03 | 7 | 106 | 2 | M27907 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 1.15e-03 | 7 | 106 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 1.15e-03 | 7 | 106 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 1.15e-03 | 7 | 106 | 2 | M47430 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 1.18e-03 | 28 | 106 | 3 | M41724 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.19e-03 | 418 | 106 | 10 | MM15587 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 1.27e-03 | 107 | 106 | 5 | M48260 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 1.31e-03 | 29 | 106 | 3 | M39616 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.31e-03 | 29 | 106 | 3 | M27309 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 1.43e-03 | 110 | 106 | 5 | M27162 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 1.45e-03 | 30 | 106 | 3 | M41825 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 1.45e-03 | 30 | 106 | 3 | M76 | |
| Pathway | PID_NECTIN_PATHWAY | 1.45e-03 | 30 | 106 | 3 | M72 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 1.52e-03 | 66 | 106 | 4 | M39642 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.52e-03 | 66 | 106 | 4 | MM14990 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.52e-03 | 8 | 106 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.52e-03 | 8 | 106 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.52e-03 | 8 | 106 | 2 | M47715 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 1.59e-03 | 31 | 106 | 3 | M661 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 1.59e-03 | 31 | 106 | 3 | M46423 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.61e-03 | 113 | 106 | 5 | MM14783 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.70e-03 | 68 | 106 | 4 | M39456 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.70e-03 | 68 | 106 | 4 | M48322 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 1.75e-03 | 32 | 106 | 3 | M275 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.75e-03 | 32 | 106 | 3 | M23 | |
| Pathway | PID_CDC42_PATHWAY | 1.89e-03 | 70 | 106 | 4 | M81 | |
| Pubmed | 3.21e-11 | 83 | 132 | 9 | 11114734 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 9799234 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 1381360 | ||
| Pubmed | Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. | 2.46e-08 | 9 | 132 | 4 | 18697750 | |
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 3.26e-08 | 49 | 132 | 6 | 15588985 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TRIO LMTK2 LCK USP31 IPO9 LMO7 NEURL1 MAP3K10 KIF14 AFDN RABGEF1 BAIAP2 MAP3K21 HECTD1 OTOG DYRK2 | 1.88e-07 | 861 | 132 | 16 | 36931259 |
| Pubmed | STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. | 2.13e-07 | 4 | 132 | 3 | 9880255 | |
| Pubmed | STAT protein recruitment and activation in c-Kit deletion mutants. | 2.13e-07 | 4 | 132 | 3 | 10358045 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 15498858 | ||
| Pubmed | 3.48e-07 | 16 | 132 | 4 | 11071635 | ||
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | SRC OBSL1 CAMK1 LCK YES1 STAT5A KMT2C PIK3CA CCDC87 FER BAIAP2 | 5.17e-07 | 410 | 132 | 11 | 25814554 |
| Pubmed | Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. | 5.31e-07 | 5 | 132 | 3 | 10617656 | |
| Pubmed | PTPN2 regulates T cell lineage commitment and αβ versus γδ specification. | 5.31e-07 | 5 | 132 | 3 | 28798028 | |
| Pubmed | Direct interaction between Kit and the interleukin-7 receptor. | 5.31e-07 | 5 | 132 | 3 | 17554063 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | HAUS6 MYO19 OBSL1 C15orf39 DNAAF11 NXN URGCP GTF2H1 IPO9 LMO7 CDC16 RAB3IP AFDN RABGEF1 BAIAP2 DNAAF1 MAP3K21 RAB3IL1 DYRK2 | 6.35e-07 | 1321 | 132 | 19 | 27173435 |
| Pubmed | 7.35e-07 | 19 | 132 | 4 | 23616926 | ||
| Pubmed | Stat5 expression is critical for mast cell development and survival. | 1.06e-06 | 6 | 132 | 3 | 12714518 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 12923167 | ||
| Pubmed | Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. | 1.06e-06 | 6 | 132 | 3 | 2404338 | |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 23871207 | ||
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 10858437 | ||
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 12538589 | ||
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 12640114 | ||
| Pubmed | Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis. | 2.95e-06 | 8 | 132 | 3 | 31101761 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRIO SRC CHD3 NXN LIN52 ZNF595 STAT5B CUL5 RLF KMT2C FAM120A PLPP1 RAB3IP SCAF11 BAIAP2 ARIH1 HECTD1 NBR1 MOCOS | 3.68e-06 | 1489 | 132 | 19 | 28611215 |
| Pubmed | 3.78e-06 | 28 | 132 | 4 | 18067320 | ||
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 6.56e-06 | 32 | 132 | 4 | 7542761 | |
| Pubmed | EEFSEC MYO19 PARG OBSL1 C15orf39 CHD3 URGCP STAT5B CUL5 FAM120A AFDN MOCOS | 7.46e-06 | 650 | 132 | 12 | 38777146 | |
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 18499741 | ||
| Pubmed | 8.91e-06 | 73 | 132 | 5 | 24728074 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | TRIO STK17A SRC OBSL1 RET LCK TEC YES1 MYOF GTF2H1 CDC16 FER MAP3K21 DYRK2 | 1.01e-05 | 910 | 132 | 14 | 36736316 |
| Pubmed | 1.12e-05 | 276 | 132 | 8 | 28319085 | ||
| Pubmed | 1.16e-05 | 77 | 132 | 5 | 22973453 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23151802 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10070972 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26999798 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8020561 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.43e-05 | 2 | 132 | 2 | 31443474 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12377952 | ||
| Pubmed | Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations. | 1.43e-05 | 2 | 132 | 2 | 25120743 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8478593 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.43e-05 | 2 | 132 | 2 | 21127177 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 16289657 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25552366 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25470773 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29715092 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.43e-05 | 2 | 132 | 2 | 21431790 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28500076 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21826656 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.43e-05 | 2 | 132 | 2 | 27264955 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22159083 | ||
| Pubmed | Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression. | 1.43e-05 | 2 | 132 | 2 | 25867068 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20008792 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33199496 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19147357 | ||
| Pubmed | Smchd1 is a maternal effect gene required for genomic imprinting. | 1.43e-05 | 2 | 132 | 2 | 33186096 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 16502315 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12217382 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31599926 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10594041 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18455992 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21036145 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21901128 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10486277 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 9788619 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 7507074 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 1.43e-05 | 2 | 132 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 1.43e-05 | 2 | 132 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 1.43e-05 | 2 | 132 | 2 | 30377054 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 1.43e-05 | 2 | 132 | 2 | 32790723 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18492722 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10066807 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10835485 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35464049 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 1.43e-05 | 2 | 132 | 2 | 23773921 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17360981 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 1.43e-05 | 2 | 132 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 1.43e-05 | 2 | 132 | 2 | 24878107 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26040420 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12847485 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12835478 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 1.43e-05 | 2 | 132 | 2 | 24497979 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 1.43e-05 | 2 | 132 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 1.43e-05 | 2 | 132 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 1.43e-05 | 2 | 132 | 2 | 10486314 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 1.43e-05 | 2 | 132 | 2 | 24497923 | |
| Pubmed | Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival. | 1.43e-05 | 2 | 132 | 2 | 14766744 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 1.43e-05 | 2 | 132 | 2 | 29460051 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28606561 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 1.43e-05 | 2 | 132 | 2 | 12393407 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20142273 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12039059 | ||
| Interaction | HSP90AB1 interactions | HGH1 PDK4 MYO19 SRC DNAH2 OBSL1 CHD3 RET LCK YES1 CUL5 KMT2C FER MAP3K10 KIF14 RABGEF1 SCAF11 MAP3K21 USP48 HECTD1 NBR1 | 8.71e-07 | 960 | 130 | 21 | int:HSP90AB1 |
| Interaction | KIT interactions | 1.51e-06 | 125 | 130 | 8 | int:KIT | |
| Interaction | DOK1 interactions | 2.18e-06 | 59 | 130 | 6 | int:DOK1 | |
| Interaction | PSIP1 interactions | 7.45e-06 | 205 | 130 | 9 | int:PSIP1 | |
| Interaction | FLOT2 interactions | 1.64e-05 | 285 | 130 | 10 | int:FLOT2 | |
| Interaction | STAT5A interactions | 2.27e-05 | 131 | 130 | 7 | int:STAT5A | |
| Interaction | CPAP interactions | 2.41e-05 | 182 | 130 | 8 | int:CPAP | |
| Interaction | IGSF9B interactions | 3.04e-05 | 10 | 130 | 3 | int:IGSF9B | |
| Interaction | STAT3 interactions | ESR2 SRC RET LCK STAT5A STAT5B MYOF CCDC87 FER OCIAD2 SCAF11 HECTD1 | 3.25e-05 | 446 | 130 | 12 | int:STAT3 |
| Interaction | DSG2 interactions | 4.33e-05 | 256 | 130 | 9 | int:DSG2 | |
| Interaction | PIK3R3 interactions | 4.40e-05 | 198 | 130 | 8 | int:PIK3R3 | |
| Interaction | FRS2 interactions | 5.21e-05 | 102 | 130 | 6 | int:FRS2 | |
| Interaction | CTNND1 interactions | 5.66e-05 | 265 | 130 | 9 | int:CTNND1 | |
| Interaction | STAP2 interactions | 5.85e-05 | 33 | 130 | 4 | int:STAP2 | |
| Interaction | DLAT interactions | 6.35e-05 | 269 | 130 | 9 | int:DLAT | |
| Interaction | GSN interactions | 7.12e-05 | 212 | 130 | 8 | int:GSN | |
| Interaction | CHTOP interactions | 7.12e-05 | 212 | 130 | 8 | int:CHTOP | |
| Interaction | CBLB interactions | 1.02e-04 | 115 | 130 | 6 | int:CBLB | |
| Interaction | CFAP45 interactions | 1.13e-04 | 15 | 130 | 3 | int:CFAP45 | |
| Interaction | CISH interactions | 1.26e-04 | 40 | 130 | 4 | int:CISH | |
| Interaction | PWP2 interactions | 1.28e-04 | 172 | 130 | 7 | int:PWP2 | |
| Interaction | PTPN11 interactions | 1.39e-04 | 368 | 130 | 10 | int:PTPN11 | |
| Interaction | SEC31A interactions | 1.50e-04 | 236 | 130 | 8 | int:SEC31A | |
| Interaction | SHROOM3 interactions | 1.50e-04 | 78 | 130 | 5 | int:SHROOM3 | |
| GeneFamily | SH2 domain containing | 6.03e-07 | 101 | 88 | 7 | 741 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.40e-06 | 40 | 88 | 5 | 321 | |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | 1.61e-05 | 372 | 128 | 11 | GSM538288_500 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 178 | 132 | 7 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 178 | 132 | 7 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.20e-06 | 199 | 132 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Influenza_Severe-CD4+_CTL|World / Disease group and Cell class | 6.45e-06 | 153 | 132 | 6 | 0c6c2c6dbc81badd886f125f4e5ba0fb7d52101c | |
| ToppCell | Influenza_Severe-CD4+_CTL|Influenza_Severe / Disease group and Cell class | 9.59e-06 | 164 | 132 | 6 | 9ffd40ae1f39290840bea79fa4e73cb7e009f310 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 177 | 132 | 6 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 180 | 132 | 6 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 181 | 132 | 6 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.73e-05 | 182 | 132 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.73e-05 | 182 | 132 | 6 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 183 | 132 | 6 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epi_progenitor|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-05 | 183 | 132 | 6 | 031b4ffd95114dc10d2932c67d2cfef139b3fd2e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 185 | 132 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.08e-05 | 188 | 132 | 6 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.14e-05 | 189 | 132 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 190 | 132 | 6 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 191 | 132 | 6 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-05 | 191 | 132 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-05 | 191 | 132 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-05 | 191 | 132 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 192 | 132 | 6 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.41e-05 | 193 | 132 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.41e-05 | 193 | 132 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.41e-05 | 193 | 132 | 6 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.41e-05 | 193 | 132 | 6 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | Control-Lymphocyte-T_NK-NK_CD56bright|Control / Disease, Lineage and Cell Type | 2.63e-05 | 196 | 132 | 6 | c0ebef067aa333c7a18c697031b0417b3335b75c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.63e-05 | 196 | 132 | 6 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.70e-05 | 197 | 132 | 6 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 197 | 132 | 6 | f097e729f515e7945b9482e9f9dbc9536b90f0bb | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.78e-05 | 198 | 132 | 6 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | wk_15-18-Epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.78e-05 | 198 | 132 | 6 | 12bbe77c3d68bf1e545949dbb1eb49ed3641de3d | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_T_naive|Leuk-UTI / Disease, condition lineage and cell class | 2.86e-05 | 199 | 132 | 6 | 476daaa0b764f82a0dfb85cc94e5b07a091703bd | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_CD56bright|Control / Disease, condition lineage and cell class | 2.94e-05 | 200 | 132 | 6 | d843fe0781c7699afead4429c526441c6fdb8cba | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 2.94e-05 | 200 | 132 | 6 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT1|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.94e-05 | 200 | 132 | 6 | b746dcc94814bcbca63c71e6451a9c5f084bcfaf | |
| ToppCell | mild-NK_CD56bright|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.94e-05 | 200 | 132 | 6 | 6de701985a0b92a7dece1b0e4a76e13756ccc0dd | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 70 | 132 | 4 | 37e34ef782b253c43628d5bb2fe5e0294573d0ef | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.33e-05 | 141 | 132 | 5 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Ptgfr_(Postsubiculum)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.59e-05 | 73 | 132 | 4 | 27644d9b67ef933af0c77936cabdbd81f05c8562 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Ptgfr_(Postsubiculum)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.59e-05 | 73 | 132 | 4 | e97b773931a64f7356f44c6950186f7bbbeb3e8d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.21e-05 | 149 | 132 | 5 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 151 | 132 | 5 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 151 | 132 | 5 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-05 | 151 | 132 | 5 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 8.75e-05 | 151 | 132 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 154 | 132 | 5 | bd283c2367afb99294e7576a0c0167eb7c69ad6b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 156 | 132 | 5 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 163 | 132 | 5 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 163 | 132 | 5 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 163 | 132 | 5 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 132 | 5 | a187bd5beca017ef657ef07c006e7f94ea3b911b | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 132 | 5 | cbdb7e893cb3959b9920c0c7c535ace03a5f4986 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 132 | 5 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 132 | 5 | 7a51365bad2910c130bd952805f7a1bef51be481 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 132 | 5 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 167 | 132 | 5 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | 92ddabbe55315856d8ea6f8db1560b6d97636bac | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 167 | 132 | 5 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | severe_influenza-CD4+_CTL|severe_influenza / disease group, cell group and cell class (v2) | 1.44e-04 | 168 | 132 | 5 | 50697fda702a09d9a621e9f79c2b52d53792dd2a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-04 | 168 | 132 | 5 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 169 | 132 | 5 | 780fb0050852626062a729dd1b82b0cf61e7e9ca | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 169 | 132 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 169 | 132 | 5 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 169 | 132 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 1.52e-04 | 170 | 132 | 5 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.52e-04 | 170 | 132 | 5 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-04 | 171 | 132 | 5 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 172 | 132 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 1.61e-04 | 172 | 132 | 5 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 172 | 132 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-04 | 172 | 132 | 5 | 30f4979abf0218618a56afb06aa6afc23ad838ec | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.70e-04 | 174 | 132 | 5 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 1.75e-04 | 175 | 132 | 5 | d7e24ac683ff36f7ce3d1151353d3d4a6f2b63bf | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 176 | 132 | 5 | ac83a6cd4bcbb9ca1fc02a9fbd9d9629ef1df8ca | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 177 | 132 | 5 | 0d894a14ddbb2734557743e9efdb89cee5c26769 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 177 | 132 | 5 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 177 | 132 | 5 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 178 | 132 | 5 | b4b4e021e86d1d523fa40695cb0a91021dee27d1 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 178 | 132 | 5 | d32b4e9c3d1f246ad49e2d8f6497989af68a6c00 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 178 | 132 | 5 | b7abf5656233e1a9cdbbe978dfa84d16f14b0be0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 179 | 132 | 5 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 179 | 132 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-04 | 179 | 132 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 179 | 132 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 180 | 132 | 5 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 181 | 132 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_Naive|Leuk-UTI / Disease, Lineage and Cell Type | 2.09e-04 | 182 | 132 | 5 | 3500a826d86beb98980e2b24e074b02e8e2f957e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.09e-04 | 182 | 132 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Th17|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-04 | 183 | 132 | 5 | 1ee09af56dac121c841d869021ca625dd3336b84 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.20e-04 | 184 | 132 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 185 | 132 | 5 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-04 | 185 | 132 | 5 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.26e-04 | 185 | 132 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.26e-04 | 185 | 132 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 186 | 132 | 5 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-04 | 186 | 132 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| Drug | Dasatinib | 1.38e-09 | 10 | 130 | 5 | DB01254 | |
| Drug | sunitinib | 6.00e-08 | 130 | 130 | 9 | CID005329102 | |
| Drug | ponatinib | 1.22e-07 | 68 | 130 | 7 | ctd:C545373 | |
| Drug | imatinib | STK17A ROR1 SRC RET LCK TEC YES1 F11 RYK STAT5A STAT5B PIK3CA FER KIT | 1.78e-07 | 430 | 130 | 14 | CID000005291 |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.93e-07 | 196 | 130 | 10 | 1666_UP | |
| Drug | methoxyacetic acid | RIPK3 ESR2 SRC LCK TEC TBC1D8B RYK STAT5A RAB3IP RABGEF1 DYRK2 | 4.79e-07 | 272 | 130 | 11 | ctd:C013598 |
| Drug | EKB-569 | 6.72e-07 | 87 | 130 | 7 | CID006445562 | |
| Drug | trichostatin A; Up 200; 0.1uM; PC3; HG-U133A | 1.57e-06 | 191 | 130 | 9 | 448_UP | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 3414_UP | |
| Drug | nilotinib | 2.02e-05 | 58 | 130 | 5 | CID000644241 | |
| Drug | N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine | 2.12e-05 | 10 | 130 | 3 | ctd:C524250 | |
| Drug | vandetanib | 2.24e-05 | 99 | 130 | 6 | CID003081361 | |
| Drug | sorafenib | 2.41e-05 | 149 | 130 | 7 | ctd:C471405 | |
| Drug | 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine | 3.24e-05 | 2 | 130 | 2 | DB03023 | |
| Drug | AC1Q5QKQ | 3.85e-05 | 12 | 130 | 3 | CID000134162 | |
| Drug | guanidinoethylmercaptosuccinic acid | 4.63e-05 | 35 | 130 | 4 | CID000003464 | |
| Drug | dasatinib | 5.05e-05 | 70 | 130 | 5 | CID003062316 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 5.14e-06 | 26 | 131 | 4 | DOID:234 (is_implicated_in) | |
| Disease | Vascular anomaly | 1.96e-05 | 2 | 131 | 2 | C0158570 | |
| Disease | Familial medullary thyroid carcinoma | 5.85e-05 | 3 | 131 | 2 | C1833921 | |
| Disease | Metastatic melanoma | 9.88e-05 | 54 | 131 | 4 | C0278883 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.17e-04 | 4 | 131 | 2 | EFO_0020830 | |
| Disease | carcinoma (implicated_via_orthology) | 1.92e-04 | 64 | 131 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | platelet-activating factor measurement | 1.94e-04 | 5 | 131 | 2 | EFO_0801075 | |
| Disease | Colorectal Neoplasms | 2.47e-04 | 277 | 131 | 7 | C0009404 | |
| Disease | Noonan syndrome (is_marker_for) | 2.90e-04 | 6 | 131 | 2 | DOID:3490 (is_marker_for) | |
| Disease | colorectal cancer (implicated_via_orthology) | 3.18e-04 | 30 | 131 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.86e-04 | 32 | 131 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | hereditary angioedema (is_implicated_in) | 4.05e-04 | 7 | 131 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | pulse pressure measurement, anxiety | 4.05e-04 | 7 | 131 | 2 | EFO_0005230, EFO_0005763 | |
| Disease | prostate carcinoma | EEFSEC HAUS6 TRIO KCTD19 ESR2 LMTK2 CHD3 CHD7 LMO7 MAP3K21 EPHA10 MOCOS | 6.34e-04 | 891 | 131 | 12 | EFO_0001663 |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 6.90e-04 | 9 | 131 | 2 | EFO_0800517 | |
| Disease | Combined immunodeficiency | 8.06e-04 | 41 | 131 | 3 | C0494261 | |
| Disease | Cutaneous Melanoma | 8.06e-04 | 41 | 131 | 3 | C0151779 | |
| Disease | kidney disease (implicated_via_orthology) | 8.06e-04 | 41 | 131 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 8.99e-04 | 96 | 131 | 4 | C1319315 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.05e-03 | 11 | 131 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 1.19e-03 | 702 | 131 | 10 | C0009402 | |
| Disease | lifestyle measurement, depressive symptom measurement | 1.25e-03 | 105 | 131 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | Paranoid Schizophrenia | 1.48e-03 | 13 | 131 | 2 | C0036349 | |
| Disease | Carcinoma, Granular Cell | 1.81e-03 | 116 | 131 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.81e-03 | 116 | 131 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.81e-03 | 116 | 131 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.81e-03 | 116 | 131 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.81e-03 | 116 | 131 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 1.81e-03 | 116 | 131 | 4 | C0001418 | |
| Disease | thrombosis (is_implicated_in) | 1.98e-03 | 15 | 131 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | vascular endothelial growth factor measurement | 2.00e-03 | 56 | 131 | 3 | EFO_0004762 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 2.32e-03 | 59 | 131 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | Mammary Carcinoma, Human | 2.44e-03 | 525 | 131 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.44e-03 | 525 | 131 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 2.50e-03 | 527 | 131 | 8 | C1458155 | |
| Disease | Breast Carcinoma | 2.84e-03 | 538 | 131 | 8 | C0678222 | |
| Disease | cystathionine measurement | 3.18e-03 | 19 | 131 | 2 | EFO_0010474 | |
| Disease | Alcohol abuse | 3.33e-03 | 67 | 131 | 3 | C0085762 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 3.53e-03 | 20 | 131 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.26e-03 | 22 | 131 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Takayasu arteritis | 4.35e-03 | 148 | 131 | 4 | EFO_1001857 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRDNVERKWEVPLLP | 371 | Q96KV6 | |
| DDECPLQIFREWPSD | 321 | P55196 | |
| NSFPDWERTKLDLPL | 591 | Q76B58 | |
| SLPPFFWRQAKAEEE | 181 | P28222 | |
| VWQPEFEDCEKPERT | 1061 | Q8NDM7 | |
| EWRKFFTQCDILPKP | 96 | Q93034 | |
| WEPEKNLDCPELISE | 51 | P45973 | |
| EDPSKCSPRFWEELF | 36 | Q5T2E6 | |
| TLFCLDQPRPSKEWQ | 26 | P32238 | |
| VILDELKCSWREPPA | 86 | Q9NVE4 | |
| ERLKLCQPSLDLPEW | 2076 | Q9P2D1 | |
| WRESPTLDKTCPFLE | 231 | Q8TBN0 | |
| FRLWKDEPTMDRTCP | 321 | Q96QF0 | |
| PRKQEAESWSPDACL | 391 | Q9UJ41 | |
| WPKIERNELPNFFSD | 376 | A0A1B0GVH7 | |
| CQEESFWKRALPFSL | 46 | Q56VL3 | |
| LEACKVNPFPKDRWN | 606 | O94925 | |
| FWKFCEELDPEKPSD | 56 | Q9NWY4 | |
| PVDFEDCSDRTPWNK | 536 | Q17RG1 | |
| EADDWCIPSREPKNL | 391 | Q16654 | |
| FVECNRLLKWCPAPD | 266 | Q9Y4X5 | |
| ECKVPNSRIPTAWFR | 361 | O75147 | |
| CFESEESPDLLKPWE | 1581 | Q15058 | |
| STCPEPFARLLEECW | 326 | Q02779 | |
| FPNLKEEFPDWTTRV | 1661 | Q8NEZ4 | |
| LSRKYWNDCEPPDSR | 81 | P04196 | |
| FEKLDRASPDLWPEQ | 21 | Q52LA3 | |
| EPQKSPWCEARSLEH | 101 | Q92731 | |
| CWDADPLKRPTFKQI | 906 | P10721 | |
| PAIQKAEICPWELDD | 1471 | Q6PRD1 | |
| RISPDAWEFCQKLSE | 301 | Q6UXM1 | |
| FSWLPNPERSLEEDC | 261 | Q96H55 | |
| EDTVRRKKCPFQSWP | 251 | Q8NFR9 | |
| PESDNVEFPCLRWLD | 646 | Q8IVV2 | |
| IPQEPAFELDWSDRK | 306 | Q8N119 | |
| SLEDFPEWERCEKPL | 701 | Q86W56 | |
| SDWTFLHCLPRKPEE | 296 | P00480 | |
| CDNTRITKVPRDPFW | 671 | P22079 | |
| RACRKPDFPSWLVVS | 356 | A6NFY4 | |
| PDIEVKDWFAARPDC | 156 | Q9H4M3 | |
| DPWSLERPRFCLLSK | 106 | Q86UT5 | |
| AFDQFLPKCWTPEDV | 416 | Q8WWI1 | |
| CWKERPEDRPTFDYL | 476 | P06239 | |
| VLQFCWLSPEKRPAA | 386 | Q8IWU2 | |
| PIKSCAAFEVTRWPV | 591 | Q96EN8 | |
| PKDTIARALPFWNEE | 156 | Q8N0Y7 | |
| PELVEALAFREWTCP | 656 | Q9NZB2 | |
| DCWQKDPGERPRFSQ | 881 | Q5JZY3 | |
| LLVNCDRETPWLPKE | 151 | Q9Y2J8 | |
| LDKLRDFVASPPCWK | 71 | Q9NRR1 | |
| PNKETPCLELEFDWF | 466 | P42336 | |
| QPRCVSEKWAPFVQE | 461 | Q9NXE4 | |
| PEKRFTCEQALQHPW | 261 | Q14012 | |
| LKPWKCQELDFLADP | 686 | Q8IUM7 | |
| WPLVEIQCSPDLRFF | 71 | Q13467 | |
| KNIISPPWDFREFEV | 556 | Q13042 | |
| PPWDFREFEVEKQTA | 561 | Q13042 | |
| PDWCEQLTSKCPFLI | 2061 | Q9ULT8 | |
| DPSENRWTIKAECPQ | 466 | Q9H0H3 | |
| CDKFPPEEELQREWL | 311 | P15169 | |
| QIRCKADNTWDPEIP | 641 | P20023 | |
| SRPEPCFEKEASLWF | 106 | Q6ZS62 | |
| SPFIKPIEAECRKWE | 1056 | Q8TD57 | |
| DPWDTNECRPTEFAV | 191 | Q92847 | |
| CEKRPWRTDEAPQRL | 806 | Q5THR3 | |
| QTVFSLPANCDWKPR | 406 | P57773 | |
| CWDYKPENRPKFSEL | 796 | P16591 | |
| LDPELDRAPEGKWSC | 406 | Q12873 | |
| PSEDPTRWFTCVLKD | 66 | P03951 | |
| DLEFWNKPCLFTPES | 246 | Q86X45 | |
| DPPTKTLWLFDIDRD | 466 | P15848 | |
| RPVFPKDRACAEAWA | 281 | Q8NEP3 | |
| ETHWCAQSEKFRPPE | 86 | Q96P70 | |
| DQSLTKEVFKFCWPP | 66 | Q7Z4H7 | |
| FCWPPFDQKSDTEFR | 76 | Q7Z4H7 | |
| REWKPLEDRSCTDIP | 16 | Q8WWI5 | |
| DVNEKVCEWRPPEQL | 66 | Q6ZQY3 | |
| IWELQVPCSPSFAID | 3341 | Q9P225 | |
| WAETLASCPIDRKPF | 71 | Q99590 | |
| ACCWALDPEERPKFQ | 576 | P34925 | |
| PLFLDFLKQCLEWDP | 506 | Q92630 | |
| WEPEPDVRTACEKLI | 321 | Q9BTY7 | |
| PVPRCHLWEKSQLDE | 2651 | Q6ZRI0 | |
| VDDPDPAKWKAQLRC | 71 | O14896 | |
| PTHKPWSVCLDDRFN | 156 | Q5JXM2 | |
| PECLWEEGKEVIPTF | 181 | O95397 | |
| CWRKEPEERPTFEYL | 501 | P12931 | |
| VEDFDWCTPPKKRGL | 486 | A6NHR9 | |
| CWQEKPEGRPSFEDL | 601 | P42680 | |
| CKERIRPLSDGNSPW | 606 | Q5TCX8 | |
| RVWCSIIVDPFPSEE | 471 | Q14596 | |
| VLNDEDCREFPWHPK | 296 | Q6DKJ4 | |
| TWSLPNECEKAPFAI | 111 | Q5QGS0 | |
| PEPNWTRELELCARF | 121 | Q92696 | |
| LRPHFLDVCDPDWSK | 126 | O14494 | |
| IPWPASDRKKSECAF | 101 | Q9H3S1 | |
| PSLCWRLEEKPLEGN | 361 | O15389 | |
| FAVPDKVLWPQLCEA | 496 | P51692 | |
| FTTDPNKRWELCDIP | 246 | P00747 | |
| KVIDAEPPVIDWCRS | 641 | Q4LDE5 | |
| PTDLLPKSFWENNCK | 111 | O43704 | |
| PEDRATAEECLKHPW | 306 | Q9UEE5 | |
| FAVPDKVLWPQLCEA | 496 | P42229 | |
| WQQACADPSKIPERA | 226 | Q9UQB8 | |
| RPAQEAEEKTWLPSC | 431 | Q6ZRI6 | |
| TECWNEIPSRRPRFK | 726 | Q01973 | |
| NTTWPLPVKIFCRDE | 1071 | Q9BXT8 | |
| FCQLQWAVDPPEKHR | 511 | Q8TCY9 | |
| LISDFANPTECWEIP | 491 | Q8N1K5 | |
| WSCFPVNTPFLEEKV | 476 | P32780 | |
| CPRQQWALVEFEKPV | 406 | P57772 | |
| WALVEFEKPVTCPRL | 411 | P57772 | |
| IEFSPEEWKCLDPAQ | 11 | Q8IYB9 | |
| FPQEEWKCLDPAQRT | 16 | Q6PDB4 | |
| IEFSPEEWKCLDPAQ | 11 | Q8TB69 | |
| PFSPEALVDRKEFWA | 371 | O76050 | |
| SESELPCEVWLPFLQ | 141 | Q13129 | |
| WSSEPKDRPSFQECL | 266 | Q9Y572 | |
| HLEKDPCSFREEPQW | 1061 | Q0IIM8 | |
| PDDYRPSKECVWRIT | 481 | Q9Y6L7 | |
| PQWDKCVNFIESALP | 401 | P78562 | |
| VPWFPRKISELDKCS | 151 | Q8IWU9 | |
| QCWKQEPDKRPVFAD | 986 | P07949 | |
| IEFSPEEWKCLDPDQ | 11 | Q15928 | |
| EPWTRKEDLSQDTCP | 71 | O43296 | |
| ACEWLLGDRKPSPEE | 321 | Q9BSL1 | |
| TKEERLAPDDAWRCP | 606 | Q70CQ4 | |
| IEFSPEEWKCLDPAQ | 11 | B4DXR9 | |
| WEPLRLFCEDDQRPV | 91 | Q9C037 | |
| DKNRPCLSNWPEDTD | 726 | Q86UV5 | |
| WTPEKTNRFPSCEEL | 396 | Q9BVV6 | |
| DKPDWCLVRTTDRSP | 1691 | O75962 | |
| NLCWKKDPDERPTFE | 506 | P07947 | |
| VKLEEDCAWSQELPP | 16 | O14978 | |
| RPETSFLWFTNPCKT | 2001 | Q9NZM1 |